Redirecting abiraterone metabolism to fine tune prostate cancer anti-androgen therapy

Abiraterone blocks androgen synthesis and prolongs survival in castration-resistant prostate cancer, which is otherwise driven by intratumoral androgen synthesis(1,2). Abiraterone is metabolized in patients to D4A, which has even greater anti-tumor activity and structural similarities to endogenous...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhenfei, Alyamani, Mohammad, Li, Jianneng, Rogacki, Kevin, Abazeed, Mohamed, Upadhyay, Sunil K., Balk, Steven P., Taplin, Mary-Ellen, Auchus, Richard J., Sharifi, Nima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111629/
https://www.ncbi.nlm.nih.gov/pubmed/27225130
http://dx.doi.org/10.1038/nature17954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111629/
https://www.ncbi.nlm.nih.gov/pubmed/27225130
http://dx.doi.org/10.1038/nature17954

Ejemplares similares